Evidera’s Matthew Bending, Senior Principal and Executive Director of HTA Strategy, Market Access Consulting, will be presenting a session titled, ‘Early Integrated Scientific Advice: A Key to Optimal PRMA?’ at World Pharma Pricing and Market Access Congress, March 19-20 in Amsterdam, Netherlands. The Congress is one of Europe’s largest conferences on pricing, patient centricity, and global market access.
